Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|July 11, 2019
The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumoursFloor J E Lubberman, Winette T A van der Graaf, Lei Xu, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2019
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokineticsFloor J E Lubberman, Guillemette E Benoist, Winald Gerritsen, et al.
Critical Reviews in Oncology/Hematology|June 23, 2023
Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature reviewNienke R K Zwart, Mira D Franken, Wim J E Tissing, et al.
Drug Discovery Today|March 21, 2016
Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumorsAnnelieke E C A B Willemsen, Floor J E Lubberman, Jolien Tol, et al.
BMJ Oncology|January 31, 2025
Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapyLisanne Renting, Nienke R K Zwart, Per Magne Ueland, et al.
Biomedical Chromatography : BMC|April 4, 2017
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasmaGuillemette E Benoist, Eric van der Meulen, Floor J E Lubberman, et al.
International Journal of Cancer|January 11, 2021
The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposureStefanie D Krens, Floor J E Lubberman, Marthe van Egmond, et al.
Clinical Pharmacology and Therapeutics|May 25, 2019
The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study)Floor J E Lubberman, Hans Gelderblom, Paul Hamberg, et al.
British Journal of Cancer|July 6, 2024
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective studyMaud B A van der Kleij, Niels A D Guchelaar, Marinda Meertens, et al.
Pageof 1